Avoiding Clinical Trial Pitfalls and Bringing Products to Market Quickly
Avoiding common pitfalls in the clinical development of cell therapies is essential to keep site activation, recruitment, trial completion on track.
In a recent article, Medpace advanced therapy expertise review the challenges of cell therapy clinical development, along with the best ways to mitigate the risk of common pitfalls.
Cell and Gene Therapy
An integrated Approach
Medpace has contributed to over 130 CGT (cell and gene therapy) trials, including advancement through marketing authorization approval. This depth of experience highlights our ability to manage the most complex and innovative advanced therapy trials. Gain the Medpace advantage:
- Dedicated CGT experts for clinical trial delivery—across numerous therapeutic areas and global regions including Asia Pacific, Europe, and the US—demonstrated by 130+ cell and gene therapy trials
- Comprehensive regulatory affairs and operational experts who work collaboratively with our medical team
- Integrated laboratory services, providing an array of CGT lab capabilities for cohesive, streamlined, and standardized trial management